Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bolles, 2011, SARS-CoV and emergent coronaviruses: viral determinants of interspecies transmission, Curr. Opin. Virol., 1, 624, 10.1016/j.coviro.2011.10.012
Deming, 2006, Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants, PLoS Med., 3, e525, 10.1371/journal.pmed.0030525
Buchholz, 2004, Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity, Proc. Natl. Acad. Sci. USA, 101, 9804, 10.1073/pnas.0403492101
Bosch, 2003, The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex, J. Virol., 77, 8801, 10.1128/JVI.77.16.8801-8811.2003
Hoffmann, 2020, SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor, Cell, 181, 271, 10.1016/j.cell.2020.02.052
Wang, 2020, Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2, Cell, 181, 894, 10.1016/j.cell.2020.03.045
Tortorici, 2019, Structural insights into coronavirus entry, Adv. Virus Res., 105, 93, 10.1016/bs.aivir.2019.08.002
Li, 2005, Structure of SARS coronavirus spike receptor-binding domain complexed with receptor, Science, 309, 1864, 10.1126/science.1116480
Lu, 2013, Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26, Nature, 500, 227, 10.1038/nature12328
Walls, 2020, Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein, Cell, 181, 281, 10.1016/j.cell.2020.02.058
ter Meulen, 2006, Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants, PLoS Med., 3, e237, 10.1371/journal.pmed.0030237
Harcourt, 2020, Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States, Emerg. Infect. Dis., 26, 1266, 10.3201/eid2606.200516
Rockx, 2008, Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge, J. Virol., 82, 3220, 10.1128/JVI.02377-07
Lee, 2020, Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients, J. Infect., 10.1016/j.jinf.2020.04.019
Okba, 2020, Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease 2019 Patients, Emerg. Infect. Dis., 26, 9, 10.3201/eid2607.200841
Bloch, 2020, Deployment of convalescent plasma for the prevention and treatment of COVID-19, J. Clin. Invest., 130, 2757, 10.1172/JCI138745
Shen, 2020, Treatment of 5 Critically Ill Patients with COVID-19 with Convalescent Plasma, JAMA, 323, 1582, 10.1001/jama.2020.4783
Liu, 2006, Two-year prospective study of the humoral immune response of patients with severe acute respiratory syndrome, J. Infect. Dis., 193, 792, 10.1086/500469
Smith, 2009, Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen, Nat. Protoc., 4, 372, 10.1038/nprot.2009.3